Intersect ENT Announces Enrollment of First Patient in Phase III Study of In-Office Treatment for Recurrent Chronic Sinusitis
December 29, 2014 at 16:05 PM EST
cIntersect ENT, Inc. (Nasdaq: XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat ...
